☆ 4.2 Article

BRAF V600E Mutation of Non-Small Cell Lung Cancer in Korean Patients

MEDICINA-LITHUANIA (2023)

Related references

Note: Only part of the references are listed.

Review Oncology

How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC)

Fabrizio Tabbo et al.

Summary: The emergence of high-throughput sequencing has allowed for a deeper understanding of the molecular characteristics of non-small cell lung cancer, providing better strategies for the treatment of specific BRAF-mutated lung cancers, but there remains a lack of targeted approaches for some patients.

CANCER TREATMENT REVIEWS (2022)

Add to Collection

Article Dermatology

BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies

Corrado Zengarini et al.

Summary: This study compared the clinical and dermoscopic characteristics, response to therapy, and prognosis between MM patients with BRAF V600E and BRAF V600K mutations. The results showed that patients with BRAF V600K mutations had worse therapy response and prognosis compared to patients with BRAF V600E mutations.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Article Oncology

Selection Strategies and Practical Application of BRAF V600E-Mutated Non-Small Cell Lung Carcinoma

Inwoo Hwang et al.

Summary: This study aimed to identify predictive factors for BRAF V600E mutation in non-small cell lung carcinoma (NSCLC) and evaluate the effectiveness of the VE1 antibody as a screening method. The results showed that the frequency of BRAF V600E mutation was higher in adenocarcinomas without EGFR and ALK alterations, and the VE1 immunohistochemistry was a useful screening method.

CANCER RESEARCH AND TREATMENT (2022)

Add to Collection

Review Oncology

Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions

Mariona Riudavets et al.

Summary: This paper provides a practical, concise and updated review on the therapeutic strategies in NSCLC with BRAF mutations, emphasizing the importance of BRAF mutations in lung cancer patients and discussing the different types of BRAF mutations and current treatment approaches.

LUNG CANCER (2022)

Add to Collection

Review Oncology

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective

Ningning Yan et al.

Summary: This review summarizes the characteristics and challenges of BRAF mutations in NSCLC, as well as the treatment strategies and resistance mechanisms of BRAF-targeted therapy.

FRONTIERS IN ONCOLOGY (2022)

Add to Collection

Article Pathology

Usefulness of BRAF VE1 immunohistochemistry in non-small cell lung cancers: a multi-institutional study by 15 pathologists in Korea

Sunhee Chang et al.

Summary: This study evaluates the predictive value and interobserver agreement of BRAF VE1 IHC in NSCLC. The results demonstrate that BRAF VE1 IHC can serve as a screening test for the detection of BRAF V600E mutation in NSCLC. However, further research is needed to optimize the protocol and establish interpretation criteria for BRAF VE1 IHC.

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2022)

Add to Collection

Article Medicine, Research & Experimental

Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database

Jeff Owsley et al.

Summary: BRAF mutations are common in various cancers and can be targeted by inhibitors with good clinical activity. The research focuses on different types of BRAF mutations in tumors and their relative proportions across human cancer. Understanding these mutation types can aid in developing effective treatments for non-V600 BRAF mutations.

EXPERIMENTAL BIOLOGY AND MEDICINE (2021)

Add to Collection

Article Oncology

Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations

J. Mazieres et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Article Oncology

Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France)

Veronique Hofman et al.

LUNG CANCER (2020)

Add to Collection

Article Biotechnology & Applied Microbiology

Frequency and clinical features of BRAF mutations among patients with stage III/IV lung adenocarcinoma without EGFR/ALK aberrations

Ho Cheol Kim et al.

ONCOTARGETS AND THERAPY (2019)

Add to Collection

Article Oncology

Validation of Immunohistochemistry for the Detection of BRAF V600E-Mutated Lung Adenocarcinomas

Chien-Hung Gow et al.

CANCERS (2019)

Add to Collection

Review Oncology

BRAF in non-small cell lung cancer (NSCLC): Pickaxing another brick in the wall

Alessandro Leonetti et al.

CANCER TREATMENT REVIEWS (2018)

Add to Collection

Article Oncology

Clinical characteristics and outcome of patients with lung cancer harboring BRAF mutations

Claire Tissot et al.

LUNG CANCER (2016)

Add to Collection

Article Oncology

Clinicopathological features of nonsmall cell lung carcinomas with BRAF mutations

T. Kinno et al.

ANNALS OF ONCOLOGY (2014)

Add to Collection

Article Oncology

BRAF-mutations in non-small cell lung cancer

Odd Terje Brustugun et al.

LUNG CANCER (2014)

Add to Collection

Article Pathology

Detection of BRAF V600E Mutation With Thyroid Tissue Using Pyrosequencing Comparison With PNA-Clamping and Real-Time PCR

Seong-Ho Kang et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)

Add to Collection

Article Oncology

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients

M. Ilie et al.

ANNALS OF ONCOLOGY (2013)

Add to Collection

Article Clinical Neurology

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

David Capper et al.

ACTA NEUROPATHOLOGICA (2011)

Add to Collection

Article Oncology

Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations

Antonio Marchetti et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Article Oncology

Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations

Paul K. Paik et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Add to Collection

Article Biochemistry & Molecular Biology

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Simon A. Forbes et al.

NUCLEIC ACIDS RESEARCH (2011)

Add to Collection

Review Biochemistry & Molecular Biology

Differential regulation and properties of MAPKs

M. Raman et al.

ONCOGENE (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.